NCT07241377

A Study in Healthy Adults to Compare the Bioavailability of EPA + DHA From Two Microalgal Sources to One Fish Source and Placebo

← Hub

Registry fields

Overall status
COMPLETED
Conditions
Absorption of Omega-3, Omega-3 Supplementation, Healthy Participants
Study type
INTERVENTIONAL
Phase
PHASE3
Primary purpose
OTHER
Intervention type
DIETARY_SUPPLEMENT, OTHER
Interventions
life'sTM omega O1035DS nTG, life'sTM omega O3020DS nTG, MEG-3 3323rTG, Placebo
Lead sponsor
RDC Clinical Pty Ltd (INDUSTRY)

Cached at: 2026-09-10 09:07:54

View on ClinicalTrials.gov

Brief summary

This is a randomised, double-blind, parallel, placebo-controlled study in healthy adults to compare the absorption of two microalgal formulations, to a fish oil and a placebo. Participant will take their assigned study product for 6 weeks and attend the clinic for 4 visits.

Contact

Need a report or Korean medical writing based on this trial?